New York Life Investment Management’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.51M Buy
12,975
+1,239
+11% +$644K 0.05% 309
2025
Q4
$6.67M Buy
11,736
+290
+3% +$180K 0.06% 268
2025
Q3
$8.21M Buy
11,446
+402
+4% +$305K 0.07% 233
2025
Q2
$9.14M Buy
11,044
+341
+3% +$232K 0.09% 212
2025
Q1
$5.63M Buy
10,703
+982
+10% +$575K 0.06% 295
2024
Q4
$5.78M Buy
9,721
+115
+1% +$62.6K 0.06% 292
2024
Q3
$3.84M Sell
9,606
-201
-2% -$69.3K 0.04% 417
2024
Q2
$2.89M Buy
9,807
+121
+1% +$36.1K 0.03% 461
2024
Q1
$3.03M Sell
9,686
-368
-4% -$102K 0.03% 454
2023
Q4
$2.6M Sell
10,054
-48
-0.5% -$10.8K 0.03% 488
2023
Q3
$2.01M Buy
10,102
+78
+0.8% +$15.3K 0.02% 513
2023
Q2
$1.96M Buy
+10,024
New +$2.08M 0.02% 517

Other funds holding AXON

New York Life Investment Management's AXON Position: Q1 2026 in Review

New York Life Investment Management increased its Axon Enterprise (AXON) stake by 11% in Q1 2026, buying an estimated $644K and bringing the position to 12,975 shares worth $5.51M. The position accounts for 0.05% of the portfolio, ranked #309.

New York Life Investment Management first reported a position in AXON in Q2 2023 and has held it in 12 quarters since. The position peaked at $9.14M in Q2 2025. 1,051 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • New York Life Investment Management held 12,975 shares of Axon Enterprise worth $5.51M as of Q1 2026.
  • New York Life Investment Management bought 1,239 Axon Enterprise shares in Q1 2026, an estimated $644K.
  • Axon Enterprise made up 0.05% of New York Life Investment Management's portfolio in Q1 2026, its #309 holding.
  • New York Life Investment Management first reported a position in Axon Enterprise in Q2 2023 and has held it in 12 quarters since.
  • New York Life Investment Management's Axon Enterprise position peaked at $9.14M in Q2 2025.
  • 1,051 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.